SpaceX, Tesla, and xAI Merger Talks Intensify Amid Terafab Launch
At a glance
- SpaceX acquired xAI in an all-stock deal, making xAI a subsidiary
- The combined SpaceX-xAI entity is valued at about $1.25 trillion
- Speculation continues about a possible merger with Tesla
Recent developments involving SpaceX, Tesla, and xAI have brought renewed attention to the possibility of a merger among Elon Musk’s companies, following several high-profile strategic moves and ongoing industry speculation.
SpaceX completed the acquisition of xAI, an artificial intelligence startup founded by Elon Musk, through an all-stock transaction. This move resulted in xAI becoming a wholly owned subsidiary of SpaceX, consolidating their operations under one corporate structure.
The combined valuation of SpaceX and xAI reached approximately $1.25 trillion after the acquisition. This figure reflects the scale of the companies’ joint activities in sectors including aerospace and artificial intelligence.
On March 21, 2026, Elon Musk announced the Terafab project, which is a collaborative semiconductor manufacturing initiative involving Tesla, SpaceX, and xAI. The project aims to deliver more than one terawatt of AI computing capacity annually, signaling a coordinated approach to advancing AI hardware capabilities.
What the numbers show
- The SpaceX-xAI entity is valued at about $1.25 trillion
- Terafab was announced on March 21, 2026
- Terafab targets over one terawatt of AI compute capacity each year
Media outlets have reported ongoing discussions regarding a potential combination of Tesla with the newly formed SpaceX-xAI entity. These discussions include possible merger or acquisition scenarios, which could take place either before or after a public offering.
Bloomberg reported that SpaceX is considering a merger with either Tesla or xAI as it prepares for a possible initial public offering in mid-2026. This report aligns with other media coverage highlighting the evolving relationship among the companies.
Simply Wall St stated that speculation about a merger between Tesla and SpaceX has increased, particularly following the announcement of the Terafab project. The joint venture is viewed as a factor influencing ongoing merger discussions within the industry.
Industry reaction
Analyst Dan Ives of Wedbush Securities stated there is a growing chance that Tesla could merge in some form with the combined SpaceX-xAI entity within the next 12 to 18 months. This assessment was based on recent corporate developments and public announcements.
Multiple media sources have reported that discussions about merging or acquiring Tesla with the SpaceX-xAI entity are ongoing, with various scenarios under consideration as the companies plan for future strategic moves.
* This article is based on publicly available information at the time of writing.
Sources and further reading
- SpaceX - Wikipedia
- Tesla bull sees odds rising of Tesla merger after Musk confirms SpaceX-xAI deal
- Elon Musk is rumored to be floating merger between Tesla, xAI, and SpaceX | Electrek
- Tesla SpaceX Merger Talk Grows As Terafab Reshapes AI Ambitions - Simply Wall St News
- SpaceX–xAI deal shows Elon Musk’s supersized IPO ambitions, but complicates equity story - ION Analytics
- Terafab - Wikipedia
Note: This section is not provided in the feeds.
More on Business
-
Royal Mail Raises Stamp Prices as Delivery Targets Lowered
Stamp prices in the UK rise, with first-class now £1.80 and second-class 91p, as Royal Mail adjusts delivery targets, according to reports.
-
Nutella Jar Floats Into View During Artemis II Livestream
A Nutella jar floated in NASA's Artemis II livestream, capturing attention as the crew approached a distance record set by Apollo 13.
-
AI Search Platforms Change How Businesses Compete for Visibility
AI Overviews now comprise 68% of local searches. Businesses must adjust strategies for improved visibility in AI-driven search results, according to reports.
-
Intel Expands Focus on Advanced Chip Packaging for AI Era
Intel's Fab 9 in New Mexico resumed operations in January 2024. Revenue projections for advanced chip packaging exceed $1 billion, according to reports.
-
Trump Executive Order Sets Tariffs on Patented Drug Imports
A statement outlines tariffs reaching 100% on patented drug imports, according to reports. This aims to enhance domestic pharmaceutical production.